Ann: PharmAust Clinical Trials Update, page-96

Final Day of June ,,,,,, Update Time?
Money flowing back to Sm4ll c4p5 , sector was well oversold , especially those that have no exposure to International influence and events.
PAA does not have any sales or revenue so financials aren't effected.

MPL tablet manufacturing program successfully completed
• Motor Neuron Disease (MND) trial completion of paperwork expected May 2022
• Patient recruitment to begin June 2022
• PharmAust to undertake a Phase 2 study in COVID-19 rather than a Phase 1 study

Was I asleep for NZ dog data? as this was published but no actual data
The New Zealand site recently completed its first 28 day treatment of a dog with B cell lymphoma for a successful
trial outcome.

Best of Luck NZT Data from other Oncology Biotechs completing their Phase II trials , one has 3 x Phase III underway all during the same pandemic everyone has been experiencing ,, come on PAA , Hows that Mouse Covid Trial ? Finished?

For those that have been invested for a Long Time here , check out RAC published results , thats what data that a company is proud of looks like, detailed , charts , extensive write up and tumors removed from the Mice to show direct comparison of results and and a throw in Value $$$ of Potential Treatment.
Well worth a look , I truly recommend you have a look at what an ASX Oncology Biotech release looks like.
https://stocknessmonster.com/announcements/rac.asx-2A1381463/